{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} New Treatment Regimen Holds Promise for Patients With Advanced Bladder Cancer ((Non-Physician Credit))

Activity Steps

1 Activity
2 Take Test 3Certificate

Description

The certificate for this activity is for NON-PHYSICIANS.

Method of Participation in the Learning Process/Evaluation Method

Successful completion of this activity includes reading the entire article and successfully completing the post-quiz and an evaluation form.

Getting the Most out of the Activity

As you prepare to participate in this activity, please reflect on your practice and your patients and identify clinical challenges you hope to have addressed.

While participating in the training, identify ways you can use newly acquired knowledge, strategies, and skills to enhance patient outcomes and your own professional development.

Learning Objectives

After completing this continuing education activity you will be able to:

  1. Distinguish the significance of the exploration of complete clinical response to chemotherapy for patients with muscle-invasive bladder cancer (MIBC).
  2. Summarize the results of the study, including the safety profile, of the selected treatment regimen.

Disclosures

The author, faculty, staff, and planners have no relevant financial relationships with any ineligible organizations regarding this educational activity.

Price: $10.00

Credits:

  • ACCME 1.0 CME

Lippincott Continuing Medical Education Institute, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Lippincott Continuing Medical Education Institute, Inc. designates this enduring material for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Planner
Professions: Other Health Professional
Test Code: OTN1123
Published: November 2023
Expires: 10/31/2025
Sources: Oncology Times
Required Passing Score: 4/5 (80%)
Authors: Catlin Nalley
Categories: Hematology , Oncology
Specialties: Hematology, Oncology
Topics: Bladder , Cancer